RELATED CONTENT
NEWS
- Promedior's new $21.5M series D helps advance fibrosis portfolio, including IPF and mylelofibrosis
- Intermune's orphan Esbriet falls foul of Germany's benefit assessment
- InterMune prices Esbriet in Germany and Norway and raises $231m in equity and loans
- "Welcome home": Stromedix buy brings fibrosis drug back to Biogen
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

